ArticleCancer immunology research2015

The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development.

Alex S Hartlage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.